Predictive model for the development of hypertensive cardiopathy: A prospective cohort study

Alexis Álvarez Aliaga1, Julio César González-Aguilera2, Liliana Del Rosario Maceo-Gómez3

  • 1Servicio de Medicina Interna, Hospital General Universitario Carlos Manuel de Céspedes, Granma, Cuba; Consulta Especializada de Hipertensión Arterial, Universidad de Ciencias Médicas de Granma, Cuba. Address: Carretera Central Kilometro 1, Vía Santiago de Cuba, Bayamo, Granma, Cuba.

Medwave
|June 6, 2017
PubMed

Insights

This study developed a predictive model for hypertensive cardiopathy using risk factors in essential arterial hypertension patients. The model accurately predicts disease development over ten years, aiding in risk stratification.

Area of Science:

  • Cardiology
  • Epidemiology
  • Predictive Modeling

Background:

  • Cardiovascular disease risk stratification is crucial.
  • Hypertensive cardiopathy presents significant morbidity and mortality.
  • Effective predictive tools are needed for cardiovascular disease risk.

Purpose of the Study:

  • To evaluate a risk factor-based model for predicting hypertensive cardiopathy.
  • To assess the model's accuracy over a ten-year period.
  • To aid in risk stratification for patients with essential arterial hypertension.

Main Methods:

  • Prospective cohort study of hypertensive patients (2000-2009).
  • Development and validation of a predictive model using a split-sample approach.
  • Binary regression analysis with backward stepwise selection.

Main Results:

  • A 13-variable model accurately predicted hypertensive cardiopathy.
  • High predictive accuracy in estimation (AUC 0.985) and validation (AUC 0.963) samples.
  • Model demonstrated adequate calibration (p=0.863).

Conclusions:

  • The developed model is a valuable clinical and epidemiological surveillance tool.
  • It effectively identifies individuals at higher risk of hypertensive heart disease.
  • The model enables risk stratification over a ten-year period.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
685
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
574
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
7.4K